Jahangard‐Rafsanjani 2014.
| Methods | Randomised trial | |
| Participants | 101 participants with diabetes (intervention 51: control 50) Community pharmacy Iran Year of study: Not stated |
|
| Interventions | Intervention group received a Pharmacist–Delivered Diabetes Support Program comprising 5 monthly visits with a telephone call between visits to reinforce treatment adherence and resolve any therapy‐related problems. Education was delivered on diet management, physical activity, and diabetes complications. At the recruitment visit, patients were provided with a blood glucose self‐monitoring device and the required test strips were supplied for 1 month. Patients were trained how to use the device and were requested to document blood glucose levels every other day in a rotating schedule (fasting, post‐prandial, before lunch, before sleep). Each patient was provided with a special logbook and educational pamphlets for the diabetes medications. At each follow‐up visit, medication‐related problems, self‐care issues, and the logbook were discussed with the patient. Duration: 5 months |
|
| Outcomes | HbA1c Systolic blood pressure (BP) Diastolic BP |
|
| Notes | Funding source: Deputy of Research, Tehran University of Medical Sciences. (Project ID: 90‐04‐156‐16161) Conflict of interest: Not stated |
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Low risk | Randomisation sequence was generated based on a block randomisation algorithm (1:1 allocation ratio; block size: 4), and 2 authors who were not involved in the recruitment process had access to the randomisation list. |
| Allocation concealment (selection bias) | Low risk | Randomisation sequence was generated based on a block randomisation algorithm (1:1 allocation ratio; block size: 4), and 2 authors who were not involved in the recruitment process had access to the randomisation list. The community pharmacist requested an allocation order using telephone calls after a patient signed the informed consent form. |
| Blinding of participants and personnel (performance bias) All Outcomes/Outcome 1 | Low risk | Unclear if measurement of primary outcomes was blinded HbA1c is an objective outcome. |
| Blinding of outcome assessment (detection bias) All Outcomes/Outcome 1 | Low risk | Unclear if measurement of primary outcomes was blinded HbA1c is an objective outcome. |
| Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Between group attrition < 10%. |
| Selective reporting (reporting bias) | Low risk | Main results reported |
| Other bias | Low risk | None |